instead, reviewing your eating environment and stress levels often resolves the issue
Statements Acknowledgments The authors would like to thank Prof
Both oral and injectable GLP-1 treatments may cause nausea, vomiting, constipation, diarrhea, abdominal discomfort, and reduced food tolerance
Session Information Date: Sunday, October 26, 2025 Title: (04300469) Rheumatoid Arthritis Diagnosis, Manifestations, and Outcomes Poster I Session Type: Poster Session A Session Time: 10:30AM-12:30PM Background/Purpose: Obesity significantly increases cardiovascular morbidity and mortality in rheumatoid arthritis (RA), yet effective strategies for managing obesity-related risks in this population remain limited
However, for concentrations exceeding three g/dl, dilution with a 0.1 M phosphate buffer at pH 7.0 was necessary to obtain reliable results